Filter Results:
(37,441)
Show Results For
- All HBS Web
(117,129)
- Faculty Publications (37,441)
Show Results For
- All HBS Web
(117,129)
- Faculty Publications (37,441)
- November 2020 (Revised February 2022)
- Case
CommonSpirit Health: Integrating a Merger of Equals
By: Robert S. Huckman, Hise Gibson and Nicole Gilmore
Soon after closing the 2019 merger of Catholic Health Initiatives (CHI) and Dignity Health to create CommonSpirit Health, Lloyd Dean and Kevin Lofton-–jointly appointed to the role of CEO—must make several operational and strategic decisions related to the integration... View Details
Keywords: Health Care Delivery; Hospital; Merger; Merger Integration; Hospital Mergers; Health Information Technology; CEOs; Health Care and Treatment; Mergers and Acquisitions; Integration; Leadership; Customer Value and Value Chain; Decision Choices and Conditions; Governance; Information Technology; Health Industry; United States
Huckman, Robert S., Hise Gibson, and Nicole Gilmore. "CommonSpirit Health: Integrating a Merger of Equals." Harvard Business School Case 621-034, November 2020. (Revised February 2022.)
- December 2020
- Teaching Note
Latam Airlines and COVID-19: Seeking Bankruptcy Protection in the United States
By: Laura Alfaro
- November 2020 (Revised April 2021)
- Case
Roll-Ups and Surprise Billing: Collisions at the Intersection of Private Equity and Patient Care
By: Trevor Fetter and Kira Seiger
This case describes the increasing investment by private equity (PE) firms in patient care and other healthcare services. The case focuses on investments in physician staffing firms and roll-up strategy investments in physician practice management (PPM). Included in... View Details
Keywords: Business Ventures; Acquisition; Mergers and Acquisitions; Business Model; Change; Disruption; Fluctuation; Trends; Customers; Customer Value and Value Chain; Ethics; Fairness; Finance; Equity; Insurance; Private Equity; Geography; Geographic Scope; Health; Health Care and Treatment; Markets; Demand and Consumers; Supply and Industry; Industry Structures; Ownership; Ownership Type; Private Ownership; Relationships; Agency Theory; Business and Community Relations; Business and Shareholder Relations; Business and Stakeholder Relations; Networks; Strategy; Competition; Consolidation; Expansion; Integration; Horizontal Integration; Vertical Integration; Value; Value Creation; Health Industry; Insurance Industry; United States
Fetter, Trevor, and Kira Seiger. "Roll-Ups and Surprise Billing: Collisions at the Intersection of Private Equity and Patient Care." Harvard Business School Case 321-049, November 2020. (Revised April 2021.)
- November 2020 (Revised April 2021)
- Technical Note
Tales of Life-changing Innovations: Containing a Fearsome Pandemic | Note on the Development of HIV/AIDS Controls, Tests, and Treatments (through 2000)
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Tales of Life-changing Innovations: Containing a Fearsome Pandemic | Note on the Development of HIV/AIDS Controls, Tests, and Treatments (through 2000)." Harvard Business School Technical Note 321-052, November 2020. (Revised April 2021.)
- November 2020 (Revised May 2021)
- Technical Note
Tales of Life-changing Innovations: Early Detection, Precise Diagnoses | Note on the Development of Mammography (though 2000)
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Tales of Life-changing Innovations: Early Detection, Precise Diagnoses | Note on the Development of Mammography (though 2000)." Harvard Business School Technical Note 321-064, November 2020. (Revised May 2021.)
- November 2020 (Revised April 2021)
- Technical Note
Tales of Life-changing Innovations: Eradicating H-Pylori Infections | Note on the Development of Antibiotic Treatments for Ulcers
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Tales of Life-changing Innovations: Eradicating H-Pylori Infections | Note on the Development of Antibiotic Treatments for Ulcers." Harvard Business School Technical Note 321-053, November 2020. (Revised April 2021.)
- November 2020 (Revised April 2021)
- Technical Note
Tales of Life-Changing Innovations: Fighting Hospital Infections | Note on the Development of Cephalosporins (through 2000)
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Tales of Life-Changing Innovations: Fighting Hospital Infections | Note on the Development of Cephalosporins (through 2000)." Harvard Business School Technical Note 321-059, November 2020. (Revised April 2021.)
- November 2020 (Revised May 2021)
- Technical Note
Tales of Life-changing Innovations: Reducing Breast Cancer Risks | Note on the Development of Tamoxifen (through 1999)
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Tales of Life-changing Innovations: Reducing Breast Cancer Risks | Note on the Development of Tamoxifen (through 1999)." Harvard Business School Technical Note 321-058, November 2020. (Revised May 2021.)
- November 2020 (Revised May 2021)
- Technical Note
Tales of Life-changing Innovations: Safe and Cheap Diagnostics | Note on the Development of Ultrasound Scanning (through 2000)
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Tales of Life-changing Innovations: Safe and Cheap Diagnostics | Note on the Development of Ultrasound Scanning (through 2000)." Harvard Business School Technical Note 321-054, November 2020. (Revised May 2021.)
- November 2020
- Case
The Rise and Fall of Nokia (Abridged)
By: Juan Alcácer and Tarun Khanna
In 2013, Nokia sold its Device and Services business to Microsoft for €5.4 billion. For decades Nokia had led the telecommunications (telecom) industry in handsets and networking. By the late 2000s, however, Nokia's position as market leader in mobile devices was... View Details
Keywords: Mobile Phones; Smartphones; Mobile and Wireless Technology; Emerging Markets; Technological Innovation; Competitive Strategy; Telecommunications Industry
Alcácer, Juan, and Tarun Khanna. "The Rise and Fall of Nokia (Abridged)." Harvard Business School Case 721-414, November 2020.
- November 2020
- Teaching Note
Unilever's Response to the Future of Work
By: William R. Kerr and Bailey McAfee
Teaching Note for HBS Case No. 820-104. View Details
- November 2020 (Revised March 2023)
- Teaching Note
Unrest in Chile
By: Vincent Pons, John Masko, Rafael Di Tella and William Mullins
In 2020, Chileans would head to the ballot box to decide their country’s future. Many international observers credited Chile’s decades of neoliberal governance with turning the country into Latin America’s “Tiger,” a prosperous, diversified economy on its way to... View Details
- November 12, 2020
- Article
What We Can Learn About Unity from Hostile Takeovers
In the wake of the recent election, the United States faces a fraught, difficult transfer of power. What we know about hostile takeovers in business can provide help in finding a path forward. Leaders on the winning side of the more successful acquisitions emphasized... View Details
Kanter, Rosabeth Moss. "What We Can Learn About Unity from Hostile Takeovers." Harvard Business Review Digital Articles (November 12, 2020).
- 12 Nov 2020
- Other Presentation
Women's Leadership in the Age of COVID-19
By: R. Ely
Ely, R. "Women's Leadership in the Age of COVID-19." New York University School of Law Webinar, November 12, 2020.
- November 11, 2020
- Article
Lessons on Leading Through Chaos from U.S. Special Operations
By: Boris Groysberg and John Masko
Groysberg, Boris, and John Masko. "Lessons on Leading Through Chaos from U.S. Special Operations." Harvard Business Review Digital Articles (November 11, 2020).
- November 2020 (Revised March 2021)
- Case
Sercomm: Operating in China Amid COVID-19 and Beyond
The COVID-19 pandemic had forced a production cut in the factory of Sercomm, one of the world’s major telecom equipment producers, in China. The case explores and highlights the challenges that Chief Executive Officer James Wang faced: How could Sercomm recover and... View Details
Keywords: Emerging Markets; Information Technology; Operations; Management; Health Pandemics; Strategy; Telecommunications Industry; Manufacturing Industry; China
Choudhury, Prithwiraj, Gary P. Pisano, and Bonnie Yining Cao. "Sercomm: Operating in China Amid COVID-19 and Beyond." Harvard Business School Case 621-005, November 2020. (Revised March 2021.)
- November 2020
- Teaching Note
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
Teaching Note for HBS Case No. 221-031. When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA)... View Details
- November 2020 (Revised March 2021)
- Case
Amazon: Cult or Culture?
By: Boris Groysberg, Sarah L. Abbott and Tricia Gregg
Amazon was one of the first entrants in e-commerce. Under the leadership of founder Jeff Bezos, Amazon had expanded beyond books to manufacturing and selling a wide range of products and services globally. Bezos had built a customer-centric culture that permeated all... View Details
Keywords: Culture; Technology Companies; Retail; Human Resource Practices; Growth; Founder; Leadership; Organizational Culture; Growth Management; Information Technology; Human Resources; Talent and Talent Management; Retail Industry; Technology Industry
Groysberg, Boris, Sarah L. Abbott, and Tricia Gregg. "Amazon: Cult or Culture?" Harvard Business School Case 421-008, November 2020. (Revised March 2021.)
- Article
The Case for a COVID Vaccine Lottery
By: Scott Duke Kominers and Alex Tabarrok
Even the smartest distribution plans are complicated by a stubborn fact: We won't have enough for everyone right away. View Details
Kominers, Scott Duke, and Alex Tabarrok. "The Case for a COVID Vaccine Lottery." Bloomberg Opinion (November 9, 2020).
- November 2020
- Supplement
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details